Alzheimer's drug trial aims to boost hearing in implant users
NCT ID NCT05438264
Summary
This study is testing whether a medication called donepezil can help adults with cochlear implants understand speech better. Donepezil is currently used for Alzheimer's disease and is thought to help the brain adapt to new sounds from the implant. Fifty participants will take either donepezil or a placebo pill for three months while also trying to use their implant more often to see if it improves their hearing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILATERAL SENSORINEURAL HEARING LOSS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37203, United States
Conditions
Explore the condition pages connected to this study.